Cite
HARVARD Citation
Pan, Z. et al. (n.d.). 505PApatinib plus docetaxel as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC) (NCT02780778). Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pan, Z. et al. (n.d.). 505PApatinib plus docetaxel as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC) (NCT02780778). Annals of oncology. p. . [Online].